Medison Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Medison Pharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10824
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medison Pharma Ltd (Medison) is marketing company which supplies and markets health care solutions to health maintenance organizations (HMO’s), medical centers, and physicians in Israel and Romania. The company offers pharmaceuticals, medical devices, and diagnostic products in the areas of neurology, oncology, human genetics, nephrology, ADHD, cardiology, hematology, aesthetics, endocrinology, infectious diseases, and allergology. Medison provides integrated services for international healthcare companies to expand their presence in Israel and Romanian healthcare markets. The company works in partnership with multinational companies which include Amgen, Inc., Ipsen SA, Shire Plc, and others. It has operations with office in Romania. Medison is headquartered in Petach Tikva, Israel.

Medison Pharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medison Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medison Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Camurus and Medison Pharma Enter into Agreement 11
Tesaro and Medison Pharma Enter into Distribution Agreement 12
Licensing Agreements 13
Medison Pharma Enters into Licensing Agreement with Puma Biotechnology 13
Medison Pharma Enters into Licensing Agreement with Resverlogix 14
Apeiron Biologics Enters into Licensing Agreement with Medison Pharma for APN311 15
Regulon Enters Into Licensing Agreement With Medison For Lipoplatin 16
Medison Pharma Ltd – Key Competitors 17
Medison Pharma Ltd – Key Employees 18
Medison Pharma Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medison Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medison Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Medison Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Camurus and Medison Pharma Enter into Agreement 11
Tesaro and Medison Pharma Enter into Distribution Agreement 12
Medison Pharma Enters into Licensing Agreement with Puma Biotechnology 13
Medison Pharma Enters into Licensing Agreement with Resverlogix 14
Apeiron Biologics Enters into Licensing Agreement with Medison Pharma for APN311 15
Regulon Enters Into Licensing Agreement With Medison For Lipoplatin 16
Medison Pharma Ltd, Key Competitors 17
Medison Pharma Ltd, Key Employees 18
Medison Pharma Ltd, Subsidiaries 19

List of Figures
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medison Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Medison Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Torii Pharmaceutical Co Ltd (4551):製薬・医療:M&Aディール及び事業提携情報
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • At Home Group Inc. (HOME):企業の財務・戦略的SWOT分析
    At Home Group Inc. (HOME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Wuxi Pharmatech (Cayman) Inc:企業のM&A・事業提携・投資動向
    Wuxi Pharmatech (Cayman) Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wuxi Pharmatech (Cayman) Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Chugach Electric Association, Inc.:発電所・企業SWOT分析
    Chugach Electric Association, Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • Intuitive Surgical Inc (ISRG):企業の財務・戦略的SWOT分析
    Intuitive Surgical Inc (ISRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • PTT Global Chemical Public Co Ltd (PTTGC):企業の財務・戦略的SWOT分析
    PTT Global Chemical Public Co Ltd (PTTGC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • CH2M HILL Companies, Ltd.:戦略・SWOT・企業財務分析
    CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Pure Technologies Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Pure Technologies Ltd. (Pure Technologies) develops technologies for inspection, monitoring and management of physical infrastructure such as buildings, water and hydrocarbon pipelines, and bridges. It provides proprietary monitoring equipment for pipelines, bridges and structures; technical …
  • Medical Developments International Ltd (MVP):企業の財務・戦略的SWOT分析
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company provides products such as penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products whic …
  • Telenor ASA:企業の戦略・SWOT・財務分析
    Telenor ASA - Strategy, SWOT and Corporate Finance Report Summary Telenor ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Veracyte Inc (VCYT):企業の製品パイプライン分析
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products comprise Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It als …
  • LGT Bank Ltd.:企業の戦略・SWOT・財務分析
    LGT Bank Ltd. - Strategy, SWOT and Corporate Finance Report Summary LGT Bank Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Getinge AB (GETI B)-医療機器分野:企業M&A・提携分析
    Summary Getinge AB (Getinge) is a global medical technology company that designs, develops and markets equipment and instruments in the areas of surgery, infection control, intensive care, care ergonomics and wound care. Its major products include surgical tables, lights, ventilators and anesthesia …
  • Relation Insurance Services, Inc:企業の戦略・SWOT・財務分析
    Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report Summary Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Donaldson Company, Inc.:企業の戦略・SWOT・財務分析
    Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • OJSC Dixy Group:企業の戦略・SWOT・財務情報
    OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report Summary OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pain Therapeutics, Inc.:企業の戦略・SWOT・財務情報
    Pain Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pain Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Allergan plc:企業の戦略・SWOT・財務情報
    Allergan plc - Strategy, SWOT and Corporate Finance Report Summary Allergan plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • The Wharf (Holdings) Limited:企業の戦略・SWOT・財務情報
    The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Melrose Industries PLC (MRO):企業の財務・戦略的SWOT分析
    Summary Melrose Industries PLC (Melrose) is an investment company that improve and sell industrial and manufacturing businesses. The company offers products such as air management, security, home automation and ergonomic and electricity generating equipment. Its business portfolio comprises of Norte …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆